Trial Details
NoneBasic Information
| Clinical ID | c3319 |
|---|---|
| Identifier | NL-OMON31889 |
| Trial Title | Chemopreventive effects of 5-ASA and UDCA in Ulcerative Colitis:__ A Double-blind, Randomized Placebo-controlled Pilot Study__ - CRC chemoprevention in UC |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory bowel disease ulcerative colitis;10017969;10017991 |
| Interventions | There will be three groups: 1) This group will receive 5-ASA 4g (4 sachets of 1000mg) a day and UDCA in tablets of 500mg in a dosage of 20-30 mg/kg a day 2) This group will receive 5-ASA 4g (4 sachets of 1000mg) a day and a placebo of UDCA in tablets of 500mg in a dosage of 20-30 mg/kg a day 3) This group will receive a placebo of both drugs |
Participant Information
| Sponsor | Universitair Medisch Centrum Utrecht |
|---|---|
| City | - |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | ADULT, ELDER, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |